Literature DB >> 6672073

Cimetidine does not correct circulating calcium and parathyroid hormone in primary hyperparathyroidism.

A Kristoffersson, S Dahlgren, J Järhult, L Wählby.   

Abstract

Thirteen patients with primary hyperparathyroidism were treated for 4-8 weeks with the H2-blocker cimetidine at a daily dose of 1 g. The drug had no effect on the serum concentrations of calcium or parathyroid hormone, nor did any of the patients improve clinically during the period of treatment. The recently reported efficacy of cimetidine in primary hyperparathyroidism is strongly questioned by the present results.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6672073     DOI： 10.1007/BF03348350

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN： 0391-4097            Impact factor:   4.256


  13 in total

1.  Effects of cimetidine on parathyroid hormone metabolism.

Authors:  C E Fiore; L S Malatino; J A Kanis
Journal:  Lancet       Date:  1981-02-28       Impact factor: 79.321

2.  Effect of cimetidine on circulating parathyroid hormone in primary hyperparathyroidism.

Authors:  J K Sherwood; F W Ackroyd; M Garcia
Journal:  Lancet       Date:  1980-03-22       Impact factor: 79.321

3.  Reduction by cimetidine of serum parathyroid hormone levels in uremic patients.

Authors:  A I Jacob; D Lanier; J Canterbury; J J Bourgoignie
Journal:  N Engl J Med       Date:  1980-03-20       Impact factor: 91.245

4.  Cimetidine and parathyroid hormone levels.

Authors:  J L Vanherweghem; N Bourgeois; M Fuss
Journal:  N Engl J Med       Date:  1980-08-14       Impact factor: 91.245

5.  Human parathyroid adenoma adenylate cyclase: stimulation by histamine that is blocked by cimetidine.

Authors:  I Klein; D C Lehotay; C G Watson; B Rogerson; G S Levey
Journal:  Metabolism       Date:  1981-07       Impact factor: 8.694

6.  Histamine receptors on dispersed parathyroid cells from pathological human parathyroid tissue.

Authors:  E M Brown
Journal:  J Clin Endocrinol Metab       Date:  1980-12       Impact factor: 5.958

7.  Cimetidine and circulating calciotropic hormone levels in uremic patients: evidence for a suppressive effect on calcitonin secretion.

Authors:  J L Sebert; P H Decourcelles; P Morinière; C Calmette; J Gueris; R Makdassi; J Khassouf; M Andrejak; A Fournier
Journal:  Miner Electrolyte Metab       Date:  1982-12

8.  Treatment with cimetidine in patients with primary hyperparathyroidism.

Authors:  S Ljunghall; G Akerström; C Rudberg; O Selking; H Johansson; L Wide
Journal:  Acta Endocrinol (Copenh)       Date:  1982-04

9.  Failure of cimetidine to affect calcium homeostasis in familial primary hyperparathyroidism (multiple endocrine neoplasia, type 1).

Authors:  M F Robinson; A B Hayles; H Heath
Journal:  J Clin Endocrinol Metab       Date:  1980-10       Impact factor: 5.958

10.  Histamine and human parathyroid adenoma: effect on adenosine 3',5'-monophosphate accumulation in vitro.

Authors:  H E Abbound; D Zimmerman; A J Edis; H Heath; T P Dousa
Journal:  J Clin Endocrinol Metab       Date:  1981-08       Impact factor: 5.958
View more
  1 in total

1.  Prevention of parathyroid hormone-dependent nephrocalcinosis by chronic administration of the organic phosphorothioate WR-2721.

Authors:  S Hirschel-Scholz; J Caverzasio; J P Bonjour
Journal:  Calcif Tissue Int       Date:  1987-02       Impact factor: 4.333
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.